Current Use of Polymers in Drug Delivery and Drug Delivery Systems (DDS) relying on Specific Molecules

CHALLENGE

A private equity firm engaged a boutique consulting firm to perform a commercial due diligence (CDD) project focused on the current use of polymers in drug delivery and drug delivery systems (DDS) that rely on specific molecules. The aim was to provide an in-depth analysis of how polymers are employed in drug delivery technologies, their impact on system performance, and market trends.

BTHT APPROACH

After a comprehensive initial consultation with the consulting firm and a clear definition of the project’s objectives, the BTHT team identified and reached out to key experts in the field. They connected with Manufacturing Executives who specialize in drug delivery systems and the application of polymers. The BTHT team arranged and facilitated a series of expert calls, ensuring each discussion was both thorough and free of technical issues.

OUTCOME

The BTHT team’s targeted approach provided the private equity firm with valuable insights from top Manufacturing Executives. The expert calls delivered detailed information on the use of polymers in drug delivery systems, including current applications, technological advancements, and market trends. This deep understanding of the polymer-based DDS landscape enabled the consulting firm to offer the private equity client a comprehensive and well-informed assessment, crucial for making strategic investment decisions.